Freeman Christopher, Cottrell W Neil, Kyle Greg, Williams Ian, Nissen Lisa
School of Pharmacy, University of Queensland, Australia.
Int J Pharm Pract. 2012 Dec;20(6):395-401. doi: 10.1111/j.2042-7174.2012.00213.x. Epub 2012 Jun 1.
To describe the effect of integrating a pharmacist into the general practice team on the timeliness and completion of pharmacist-conducted medication reviews.
A pharmacist was integrated into an Australian inner-city suburb general practice medical centre to provide medication reviews for practice patients. A retrospective analysis of medication reviews with two time periods was conducted: pre-integration of the practice pharmacist and post-integration of the practice pharmacist. In an effort to obtain a measure of external validity the data were compared to data from the Division of General Practice in which the medical centre is located.
There were 70 patients referred for medication review in the pre-integration phase and 314 patients referred in the post-integration phase. The time to complete the medication review process was significantly reduced from a median of 56 days to 20 days with a practice pharmacist. Prior to having a practice pharmacist 52% of patients did not have the service billed by the general practitioner, which was reduced to 6% during the post-integration phase.
The results from this trial show that the integration of a pharmacist into the general practice team was associated with an increase in the timeliness and completion rate of medication reviews.
描述将药剂师纳入全科医疗团队对药剂师进行药物评估的及时性和完成情况的影响。
一名药剂师被纳入澳大利亚内城区的一个全科医疗中心，为该诊所的患者提供药物评估。对两个时间段的药物评估进行了回顾性分析：执业药剂师入职前和入职后。为了获得外部效度的衡量标准，将数据与该医疗中心所在的全科医疗部门的数据进行了比较。
在整合前阶段有70名患者被转诊进行药物评估，整合后阶段有314名患者被转诊。有执业药剂师参与时，完成药物评估过程的时间从中位数56天显著减少到20天。在有执业药剂师之前，52%的患者没有由全科医生计费的服务，在整合后阶段这一比例降至6%。
该试验结果表明，将药剂师纳入全科医疗团队与药物评估的及时性和完成率提高有关。
